Atlas Trials

Study to Evaluate the Safety and Efficacy of Prolastin in Hospitalized Subjects With COVID-19

Clinical trial NCT04495101 · COMPLETED

Trial details

NCT number
NCT04495101
Sponsor
Instituto Grifols, S.A.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
COVID-19
Start date
2020-07-29
Primary completion
2021-04-26
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.